The Prostate Cancer Foundation (PCF) aims to fund promising research on prostate cancer's biology and treatments, speeding up discoveries into therapies and strategies to enhance the quality of life and survival rates for patients. It fosters a unified community involving patients, researchers, caregivers, and clinicians to minimize death and suffering caused by the disease.
The Prostate Cancer Foundation champions the Young Investigator Awards to support young researchers (generally aged 35 and under) in postdoctoral fellowships or early junior faculty positions dedicated to prostate cancer research. This initiative aims to accelerate solutions for prostate cancer, focusing on ending death and suffering from the disease, particularly metastatic prostate cancer. Since 2007, PCF has funded 383 awards across 13 countries, emphasizing its significant impact and prestige in the field of cancer research. The awards, lasting three years at $75,000 annually, encourage innovative and flexible use of funds to propel the recipient's career and research. Notably, the award supports direct science costs but excludes indirect costs like institutional overhead. Awardees must work under strict mentorship, attend annual PCF scientific events, and their work should lean towards transformative research with potential immediate benefits to patients. The program openly invites global applications across various disciplines and highly values contributions toward understanding and addressing care disparities in prostate cancer. Proposals are expected to be innovative, with a preference for translational research that promises near-term patient benefits.
esse do et proident mollit veniam minim incididunt qui excepteur est fugiat incididunt laboris duis est laboris veniam veniam cillum ipsum labore in duis eu irure enim esse